SKI Market

A+| A| A-|

Indian Indices

Sensex

71,947.55 -1,635.67
( -2.22%)

Global Indices

Nasdaq

46,363.90 1,126.75
(2.49%)

Dow Jones

6,550.24 185.52
(2.91%)

Hang Seng

51,264.29 -621.56
(-1.20%)

Nikkei 225

10,176.45 48.49
(0.48%)

Forex

USD-INR

94.53 0.44
(0.47%)

EUR-INR

108.77 0.13
(0.12%)

GBP-INR

125.32 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Board of Directors

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

848.3143291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

40.58

60201.9

EPS(TTM)

Face Value()

Div & Yield %

52.57

0.12

Chairman / Executive Director / M D / Promoter	Glenn Saldanha
ED / WTD / Promoter	Cheryl Pinto
ED / President / Global CFO	Anurag Mantri
Non Executive Director	B E Saldanha
Independent Non Exe. Director	Sona Saira Ramasastry Dipankar Bhattacharjee V R Iyer Pradeep Kumar Sinha
Company Sec. & Compli. Officer	Harish Kuber

71,947.55 -1,635.67 ( -2.22%)

46,363.90 1,126.75 (2.49%)

6,550.24 185.52 (2.91%)

51,264.29 -621.56 (-1.20%)

10,176.45 48.49 (0.48%)

94.53 0.44 (0.47%)

108.77 0.13 (0.12%)

125.32 -0.25 (-0.20%)

0.59 0.00 (-0.02%)